Can GlaxoSmithKline sustain the dividend behind its eye-catching 6.5% yield? Citywire AA-rated Hugh Yarrow explains why he holds nearly 6% of his Evenlode Income Fund in the company.
Can GlaxoSmithKline sustain the dividend behind its eye-catching 6.5% yield? Citywire AA-rated Hugh Yarrow explains why he holds nearly 6% of his Evenlode Income Fund in the company.
Can GlaxoSmithKline sustain the dividend behind its eye-catching 6.5% yield? Citywire AA-rated Hugh Yarrow explains why he holds nearly 6% of his Evenlode Income Fund in the company.
Can GlaxoSmithKline sustain the dividend behind its eye-catching 6.5% yield? Citywire AA-rated Hugh Yarrow explains why he holds nearly 6% of his Evenlode Income Fund in the company.
